Neuronetics Q2 Revenue Beats, But Going Concern Warning Clouds Outlook
STIM has more than doubled off its 52-week low of $0.8 on elevated volume (12× avg).
Summary
Neuronetics beat Q2 revenue estimates with $41.6 million and improved margins, but warned it may not survive as a going concern due to a projected debt covenant breach in March 2027.
Key Events · Earnings and Guidance · STIM
-
Going Concern Warning
Substantial doubt exists about Neuronetics' ability to continue as a going concern. The company projects trailing twelve-month revenue through March 31, 2027 will be below the minimum required by its credit agreement, and it lacks the liquidity to repay the $65 million facility if called.
-
Q2 Revenue Beat, Margin Improvement
Revenue of $41.6 million grew 9% year-over-year, beating estimates. Gross margin expanded to 51.1% from 46.6% a year ago, driven by higher-margin unlocked system sales and improved revenue cycle management.
-
Dilutive ATM Usage
During Q2, Neuronetics sold 6.05 million shares under its at-the-market program at an average price of $1.31, raising $8.0 million in gross proceeds. $33.7 million remains available for future sales, representing potential further dilution.
-
Debt Covenant Amendment and Repayment
In March 2026, the company amended its credit agreement to modify revenue and liquidity covenants and made a $5.0 million principal repayment, incurring a $0.5 million loss on partial debt extinguishment.
Analysis · STIM · Industrial Applications And Services
Neuronetics delivered Q2 revenue of $41.6 million, a 9% year-over-year increase that topped estimates, while gross margin climbed to 51.1%. Yet these operational gains are overshadowed by a stark warning: management has substantial doubt about the company's ability to continue as a going concern. The trigger is a projected shortfall in trailing twelve-month revenue through March 2027, which is expected to fall below the minimum required by its credit agreement. Should the lender demand repayment of the $65 million facility, Neuronetics lacks the liquidity to comply. During the quarter, the company sold 6.05 million shares under its ATM program at an average price of $1.31, raising $8 million in gross proceeds, but this dilutive issuance only adds to the concerns.
At the time of this filing, STIM was trading at $3.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $222M. The 52-week trading range was $0.80 to $4.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.